loading...| Preferred Name |
Chloral Hydrate |
|
| Synonyms |
|
|
| Definitions |
A synthetic monohydrate of chloral with sedative, hypnotic, and anticonvulsive properties. Chloral hydrate is converted to the active compound trichloroethanol by hepatic alcohol dehydrogenase. The agent interacts with various neurotransmitter-operated ion channels, thereby enhancing gamma-aminobutyric acid (GABA)-A receptor mediated chloride currents and inhibiting amino acid receptor-activated ion currents. In addition, chloral hydrate enhances the agonistic effects of glycine receptors, inhibits AMPA-induced calcium influx in cortical neurons, and facilitates 5-HT 3 receptor-mediated currents in ganglionic neurons. Overall, this results in a depressive effect on the central nervous system. |
|
| ID |
http://purl.obolibrary.org/obo/NCIT_C28922 |
|
| CAS_Registry |
302-17-0 |
|
| CHEBI_ID |
CHEBI:28142 |
|
| Chemical_Formula |
C2H3Cl3O2 |
|
| code |
C28922 |
|
| Contributing_Source |
FDA |
|
| definition |
A synthetic monohydrate of chloral with sedative, hypnotic, and anticonvulsive properties. Chloral hydrate is converted to the active compound trichloroethanol by hepatic alcohol dehydrogenase. The agent interacts with various neurotransmitter-operated ion channels, thereby enhancing gamma-aminobutyric acid (GABA)-A receptor mediated chloride currents and inhibiting amino acid receptor-activated ion currents. In addition, chloral hydrate enhances the agonistic effects of glycine receptors, inhibits AMPA-induced calcium influx in cortical neurons, and facilitates 5-HT 3 receptor-mediated currents in ganglionic neurons. Overall, this results in a depressive effect on the central nervous system. |
|
| FDA_UNII_Code |
418M5916WG |
|
| in_subset | ||
| label |
Chloral Hydrate |
|
| Legacy Concept Name |
Chloral_Hydrate |
|
| Preferred_Name |
Chloral Hydrate |
|
| prefixIRI |
NCIT:C28922 |
|
| prefLabel |
Chloral Hydrate |
|
| Semantic_Type |
Organic Chemical Pharmacologic Substance |
|
| UMLS_CUI |
C0008161 |
|
| subClassOf |